| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871653 | The Annals of Thoracic Surgery | 2016 | 8 Pages |
Abstract
Most patients who require pneumonectomy for clinical stage IIIA NSCLC receive neoadjuvant chemoradiotherapy, without an improvement in survival. In these patients, primary resection, followed by adjuvant chemoradiotherapy, may provide equivalent long-term outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Stephen R. MD, MPHS, Aalok P. BS, BA, Traves D. MD, Jennifer M. RN, BSN, Daniel MD, Clifford G. MD, Daniel MD, PhD, A. Sasha MD, G. Alexander MD, Bryan F. MD, MPH, Varun MD, MSCI,